These findings align with the majority of experimental studies, which demonstrate that in transgenic KO mouse models for GR expression, GR deletion results in cardiac hypertrophy, dilation, and systolic dysfunction associated with heart failure (17). The gene discussed is NR3C1; the disease is cardiac hypertrophy.